Healthcare Technology
-
What Is AI in Drug Discovery? How Machine Learning Is Reshaping Biotech
Artificial intelligence has become one of the most discussed and most misunderstood concepts in the biotech sector. Some companies claim AI will compress the 15-year drug discovery timeline to a few years. Skeptics argue that AI-designed drugs are only as good as the biology they are trained on, and that the hard part of drug…
-
What Is CRISPR? Gene Editing Technology and Its Biotech Investment Implications
In 2020, Emmanuelle Charpentier and Jennifer Doudna were awarded the Nobel Prize in Chemistry for developing CRISPR-Cas9 — a gene editing technology that has been described as one of the most significant scientific advances of the twenty-first century. For biotech investors, CRISPR is not just a scientific concept; it is a foundational platform technology that…